Synexa Life Sciences is a leading brand specializing in Biomarker and Bioanalytic Research Services. With almost 20 years of experience, they offer expert insights for the clinical development of therapeutics. Their Biomarker Science expertise includes deep knowledge in biomarker selection and assay design, providing valuable insights throughout each stage of a therapeutic's development.

In addition, they offer Bioanalytical Science services, offering pharmacokinetic and immunogenicity insights into the bioanalytical profile of large molecule therapeutics. Synexa also provides innovative in vitro solutions through their unique ProtoTrials® platform, which offers translational insights into a therapeutic's potential, safety, and efficacy. Their wide range of services and capabilities include bioanalysis solutions, biomarker solutions, and custom solutions tailored to meet specific research needs.

Synexa utilizes innovative technologies and approaches to answer client-specific questions related to biomarkers at every level of the biological continuum. With a strong focus in areas such as immunology, immuno-oncology, and autoimmunity, they provide advanced bioanalytical solutions for cell and gene therapies, large and novel molecule bioanalysis, vaccines, biosimilars, and functional and translational assays. By bridging the gap between science and life, Synexa is dedicated to improving the quality of human health through their innovative biomarker and bioanalytical solutions